Recursion Pharmaceuticals Inc (RXRX) — Free Cash Flow Generation Index
Latest as of March 2022:
0.94x
Recursion Pharmaceuticals Inc (RXRX) has a Free Cash Flow Generation Index of 0.94x as of March 2022. Free cash flow of $73.05 Million represents 1% of operating cash flow ($77.39 Million). Explore RXRX capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.94x
Free Cash Flow / Operating CF
Free Cash Flow
$73.05 Million
USD
Operating Cash Flow
$77.39 Million
USD
Capital Expenditures
$4.34 Million
USD
Annual Free Cash Flow Generation for Recursion Pharmaceuticals Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Recursion Pharmaceuticals Inc. Check RXRX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).